IP Library Granted Patent US 7,947,472
Granted Patent B2
US 7,947,472 · App. 09/219,345 · Granted May 24, 2011

Expression vectors and cell lines expressing vascular endothelial growth factor D

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,947,472
App. No.
09/219,345
Granted
May 24, 2011
Kind
B2
Abstract

This invention relates to expression vectors comprising VEGF-D and its biologically active derivatives, cell lines stably expressing VEGF-D and its biologically active derivatives, and to a method of making a polypeptide using these expression vectors and host cells. The invention also relates to a method for treating and alleviating melanomas or tumors expressing VEGF-D and various diseases.

Claims (15)

1. A mammalian cell line transformed or transfected with a promoter operably linked to a VEGF-D nucleic acid, wherein the VEGF-D nucleic acid comprises a nucleotide sequence encoding a continuous portion of SEQ ID NO: 11 having a biological activity of VEGF-D selected from the group consisting of ability to stimulate one or more of endothelial cell proliferation, differentiation, migration, survival or vascular permeability,

wherein the VEGF-D nucleic acid lacks the codons encoding amino acids 203-354 of SEQ ID NO: 11; and

wherein said promoter is capable of promoting expression of the nucleic acid in a mammalian cell.

2. A mammalian cell line transformed or transfected with a promoter operably linked to a VEGF-D nucleic acid, wherein the VEGF-D nucleic acid comprises a nucleotide sequence encoding a continuous portion of SEQ ID NO: 11 having a biological activity of VEGF-D selected from the group consisting of ability to stimulate one or more of endothelial cell proliferation, differentiation, migration, survival or vascular permeability,

wherein the VEGF-D nucleic acid lacks the codons encoding amino acids 203-354 of SEQ ID NO: 11, and

wherein said cell line is the 293-EBNA human embryonal kidney cell line.

3. A mammalian call line transformed or transfected with a promoter operably linked to a VEGF-D nucleic acid, wherein the VEGF-D nucleic acid comprises a nucleotide sequence encoding a continuous portion of SEQ ID NO: 11, wherein the VEGF-D nucleic acid encodes amino acids 2-202 of SEQ ID NO: 11 and wherein the VEGF-D nucleic acid lacks the codons encoding amino acids 203-354 of SEQ ID NO: 11.

4. An expression vector comprising

a nucleic acid comprising a nucleotide sequence encoding a continuous portion of

SEQ ID NO:11 having a biological activity of VEGF-D selected from the group consisting of ability to stimulate one or more of endothelial cell proliferation, differentiation, migration, survival or vascular permeability, wherein the nucleic acid lacks the codons encoding positions 203-354 of SEQ ID NO: 11, and,

a promoter operably linked to the nucleic acid, wherein said promoter is capable of promoting expression of the nucleic acid in a mammalian cell.

5. An isolated nucleic acid comprising a nucleotide sequence encoding a continuous portion of SEQ ID NO:11 having a biological activity of VEGF-D selected from the group consisting of ability to stimulate one or more of endothelial cell proliferation, differentiation, migration, survival or vascular permeability, wherein the nucleic acid lacks the codons encoding amino acids 203-354 of SEQ ID NO: 11.

6. The isolated nucleic acid according to claim 5 , further comprising sequence that encodes an affinity tag attached in-frame to the nucleotide sequence.

7. An expression vector comprising the nucleic acid according to claim 6 .

8. An isolated host cell transformed or transfected with the isolated nucleic acid of claim 5 or the vector according claim 4 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2007
From: LUDWIG INSTITUTE FOR CANCER RESEARCH; LICENTIA LTD.
To: VEGENICS LIMITED
Reel/Frame 020243/0259 →
MERGER AND CHANGE OF NAME Recorded Jan 24, 2007
From: HELSINKI UNIVERSITY LICENSING LTD.
To: LICENTIA LTD.
Reel/Frame 018815/0306 →